Following a lengthy wait that included plenty of downside and frustration, biotechnology stocks and exchange traded funds are finding a groove. For example, the VanEck Vectors Biotech ETF (BBH) is higher by 14.23% since the start of the third quarter. There’s still work to be done as BBH is down 13.64% year-to-date, but recent price [...] The post Biotech Bounce-Back Could Be Durable appeared first on ETF Trends .